Flagship Harbor Advisors, LLC Acumen Pharmaceuticals, Inc. Transaction History
Flagship Harbor Advisors, LLC
- $1.94 Billion
- Q4 2025
A detailed history of Flagship Harbor Advisors, LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 350 shares of ABOS stock, worth $623. This represents 0.0% of its overall portfolio holdings.
Number of Shares
350Holding current value
$623% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABOS
# of Institutions
73Shares Held
36.2MCall Options Held
11.6KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA14.9MShares$26.6 Million0.46% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$6.08 Million2.33% of portfolio
-
Franklin Resources Inc San Mateo, CA2.31MShares$4.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$3.84 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$2.94 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $72.1M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...